Association of respiratory failure with inhibition of NaV1.6 in the phrenic nerve

References

• Alexandrou AJ, Brown AR, Chapman ML, et al. Subtype-Selective small molecule inhibitors reveal a fundamental role for Nav1.7 in nociceptor electrogenesis. Axonal Conduction and Presynaptic Release PLoS One. 2016;11(4):e0152405.
   PubMed Web of Science ®Google Scholar
• Israel MR, Tanaka BS, Castro J, et al. NaV1.6 regulates excitability of mechanosensitive sensory neurons. J Physiol. 2019;597(14):3751–3768.
   PubMed Web of Science ®Google Scholar
• Caldwell JH, Schaller KL, Lasher RS, et al. Sodium channel Nav1.6 is localized at nodes of Ranvier, dendrites, and synapses. Proc of Natl Acad Sciences. 2000;97(10):5616–5620.
   PubMed Web of Science ®Google Scholar
• Shiers SI, Klein RM, Price T. Quantitative differences in neuronal subpopulations between mouse and human dorsal root ganglia demonstrated with RNAScope in situ hybridization. Pain. 2020;161(10):2410–2424.
   PubMed Web of Science ®Google Scholar
• Toledo-Aral JJ, Moss BL, He ZJ, et al. Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc Natl Acad Sci USA. 1997;94(4):1527–1532.
   PubMed Web of Science ®Google Scholar
• Weiss J, Pyrski M, Jacobi E, et al. Loss-of-function mutations in sodium channel Nav1.7 cause anosmia. Nature. 2011;472(7342):186–192.
   PubMed Web of Science ®Google Scholar
• Xie W, Strong JA, Ye L, et al. Knockdown of sodium channel NaV1.6 blocks mechanical pain and abnormal bursting activity of afferent neurons in inflamed sensory ganglia. Pain. 2013;154(8):1170–1180.
   PubMed Web of Science ®Google Scholar
• Chen L, Huang J, Zhao P, et al. Conditional knockout of NaV1.6 in adult mice ameliorates neuropathic pain. Sci Rep. 2018;8:3845.
   PubMed Web of Science ®Google Scholar
• Kanchanapongkul J. Puffer fish poisoning: clinical features and management experience in 25 cases. J of the Med Association of Thail. 2001;84:385–389.
   PubMedGoogle Scholar
• Kiernan MC, Isbister GK, Lin CSY, et al. Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish. Ann Neurol. 2005;57:339–348.
   PubMed Web of Science ®Google Scholar
• Waxman SG, Merkies ISJ, Gerrits MM, et al. Sodium channel genes in pain-related disorders: phenotype-genotype associations and recommendations for clinical use. Lancet Neurol. 2014;13(11):1152–1160.
   PubMed Web of Science ®Google Scholar
• Goldberg YP, Macfarlane J, Macdonald ML, et al. Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genetics. 2007;71(4):311–319.
   PubMed Web of Science ®Google Scholar
• Nilsen KB, Nicholas AK, Woods CG, et al. Two novel SCN9A mutations causing insensitivity to pain. Pain. 2009;143(1–2):155–158.
   PubMed Web of Science ®Google Scholar
• Cox JJ, Sheynin J, Shorer Z, et al. Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations. Hum Mutation. 2010;31(9):E1670–E1686.
   PubMed Web of Science ®Google Scholar
• Ahn HS, Dib-Hajj SD, Cox JJ, et al. A new Nav1.7 sodium channel mutation I234T in a child with severe pain. Euro J of Pain. 2010;14(9):944–950.
   PubMed Web of Science ®Google Scholar
• Dabby R. Pain disorders and erythromelalgia caused by voltage-gated sodium channel mutations. Curr Neurol and Neurosci Reports. 2021;12(1):76–83.
   Google Scholar
• Sarkis RA, Goksen Y, Mu Y, et al. Cognitive and fatigue side effects of anti-epileptic drugs: an analysis of phase III add-on trials. J of Neurol. 2018;265:2137–2142.
   PubMed Web of Science ®Google Scholar
• Saoudi M, Abdelmouleh A, El Feki A. El Feki A Tetrodotoxin: a potent marine toxin. Toxin Rev. 2010;29(2):60–70.
   Web of Science ®Google Scholar
• Pero JE, Rossi MA, Lehman HDGF, et al. Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model. Bioorganic & Med Chem Letters. 2017;27(12):2683–2688.
   PubMed Web of Science ®Google Scholar
• Roecker AJ, Egbertson M, Jones KLG, et al. Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nav1.7 inhibitors with pain efficacy in mice. Bioorganic & Med Chem Letters. 2017;27(10):2087–2093.
   PubMed Web of Science ®Google Scholar
• Swain NA, Batchelor D, Beaudoin S, et al. Discovery of clinical candidate 4 [2-(5-Amino 1H pyrazol-4-yl)-4chlorophenoxy]-5-chloro-2-fluoro N 1,3-thiazol-4ylbenzenesulfonamide (PF-05089771): design and optimization of diaryl ether aryl sulfonamides as selective inhibitors of NaV1.7. J of Med Chem. 2017;60(16):7029–7042.
   PubMed Web of Science ®Google Scholar
• Greshock TJ, Mulhearn J, Guo L, et al. Preparation of diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels. WO2017106409. 2017;A1 2017–06–22.
   Google Scholar
• Roecker AJ, Layton ME, Pero JE, et al. Discovery of arylsulfonamide NaV1.7 inhibitors: IVIVC, MPO, methods, and optimization of selectivity profile. ACS Med Chem Letters. 2021;21:1038–1049.
   Google Scholar
• Vyskočil F, Gutmann E. Gutmann E control of ACh sensitivity in temporarily unconnected (“decentralized”) segments of diaphragm-muscle fibres of the rat. Pflugers Arch. 1976;367:43–47.
   PubMed Web of Science ®Google Scholar
• Borison HL, McCarthy LE, Clark WG, et al. Vomiting, hypothermia, and respiratory paralysis due to tetrodotoxin (puffer fish poison) in the cat. Toxicol and Appl Pharmacology. 1963;5:350–357.
   PubMed Web of Science ®Google Scholar
• Staiman A, Seeman P. The impulse-blocking concentrations of anesthetics, alcohols, anticonvulsants, barbiturates, and narcotics on phrenic and sciatic nerves. Can J of Physiol and Pharmacol. 1974;52(3):535–550.
   PubMed Web of Science ®Google Scholar
• Burgess D, Kohrman D, Galt J, et al. Mutation of a new sodium channel gene, Scn8a, in the mouse mutant ‘motor endplate disease.’ Nat Genetics. 1995;10:461–465.
   PubMed Web of Science ®Google Scholar
• Chen K, Godfrey DA, Ilyas O, et al. Cerebellum-Related characteristics of Scn8a-Mutant mice. Cerebellum. 2009;8:192–201.
   PubMed Web of Science ®Google Scholar
• Repentigny YD, Côté PD, Pool M, et al. Pathological and genetic analysis of the degenerating muscle (dmu) mouse: a new allele of Scn8a. Hum Mol Genetics. 2001;10(17):1819–1827.
   PubMed Web of Science ®Google Scholar
• Trudeau MM, Dalton JD, Day JW, et al. Heterozygosity for a protein truncation mutation of sodium channel SCN8A in a patient with cerebellar atrophy, ataxia, and mental retardation. J of Med Genetics. 2006;43:527–530.
   PubMed Web of Science ®Google Scholar
• Carvill GL, Heavin SB, Yendle SC, et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genetics. 2013;45:825–830.
   PubMed Web of Science ®Google Scholar
• Focken T, Burford K, Grimwood ME, et al. Identification of CNS-Penetrant aryl sulfonamides as isoform-Selective NaV1.6 inhibitors with efficacy in mouse models of epilepsy. J of Med Chem. 2019;62(21):9618–9641.
   PubMed Web of Science ®Google Scholar
• McGonigal R, Rowan EG, Greenshields KN, et al. Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. Brain. 2010;133(7):1944–1960.
   PubMedGoogle Scholar
• Feldman HS, Arthur R, Covino BG. Covino BG comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog. Anesth Analg. 1989;69:794–801.
   PubMed Web of Science ®Google Scholar
• Nancarrow C, Rutten AJ, Runciman WB, et al. Myocardial and cerebral drug concentrations and the mechanisms of death after fatal intravenous doses of lidocaine, bupivacaine, and ropivacaine in the sheep. Anesth Analg. 1989;69:276–283.
   PubMed Web of Science ®Google Scholar
• Yuan YP, Chen HF, Yang C, et al. A case of accidental intrathecal injection of a large dose of ropivacaine during cesarean section. Int J L of Clin Exp Med. 2014;7(8):2383–2385.
   PubMed Web of Science ®Google Scholar
• Conn RA, Cofield RH, Byer DE, et al. Interscalene block anesthesia for shoulder surgery. Clin Orthopaedics and Relat Res. 1987;216:94–98.
   Google Scholar
• Muroi M, Kimura I, Kimura M. Blocking effects of hypaconitine and aconitine on nerve action potentials in phrenic nerve-diaphragm muscles of mice. Neuropharmacology. 1990;29(6):567–572.
   PubMed Web of Science ®Google Scholar
• Gonçalves TC, Boukaiba R, Molgó J, et al. Direct evidence for high affinity blockade of NaV1.6 channel subtype by huwentoxin-IV spider peptide, using multiscale functional approaches. Neuropharmacology. 2018;133:404–414.
   PubMed Web of Science ®Google Scholar